Selected research
Market Structure
Global Brain AI-assisted Diagnosis Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Brain AI-assisted Diagnosis Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Brain AI-assisted Diagnosis Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Brain AI-assisted Diagnosis Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Brain AI-assisted Diagnosis Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Brain AI-assisted Diagnosis Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Brain AI-assisted Diagnosis Software include Deepwise, NeuMiva, G K Healthcare, Sense Time, United Imaging, Infervision, Shukun, FOSUN AITROX and BioMind, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Brain AI-assisted Diagnosis Software market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Brain AI-assisted Diagnosis Software and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Brain AI-assisted Diagnosis Software revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Brain AI-assisted Diagnosis Software market size, projected growth trends, production technologies, key applications, and end-use industries.
Brain AI-assisted Diagnosis Software Segment by Company
Deepwise
NeuMiva
G K Healthcare
Sense Time
United Imaging
Infervision
Shukun
FOSUN AITROX
BioMind
NANO-X
Aikenist
VUNO
Brain AI-assisted Diagnosis Software Segment by Type
Cloud-based
On-Primes
Brain AI-assisted Diagnosis Software Segment by Application
Hospital
Clinic
Imaging Center
Brain AI-assisted Diagnosis Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Brain AI-assisted Diagnosis Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Brain AI-assisted Diagnosis Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Brain AI-assisted Diagnosis Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Brain AI-assisted Diagnosis Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Brain AI-assisted Diagnosis Software industry.
Chapter 3: Detailed analysis of Brain AI-assisted Diagnosis Software companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Brain AI-assisted Diagnosis Softwarerevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Cloud-based
- On-Primes
Applications
- Hospital
- Clinic
- Imaging Center
Companies covered
- Deepwise
- NeuMiva
- G K Healthcare
- Sense Time
- United Imaging
- Infervision
- Shukun
- FOSUN AITROX
- BioMind
- NANO-X
- Aikenist
- VUNO
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Brain AI-assisted Diagnosis Software Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Cloud-based
- 1.2.3 On-Primes
- 1.3 Market Analysis by Application
- 1.3.1 Global Brain AI-assisted Diagnosis Software Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Clinic
- 1.3.4 Imaging Center
- 1.4 Global Market Growth Prospects
- 1.5 Global Brain AI-assisted Diagnosis Software Growth Trends by Region
- 1.5.1 Global Brain AI-assisted Diagnosis Software Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Brain AI-assisted Diagnosis Software Market Size by Region (2021-2026)
- 1.5.3 Brain AI-assisted Diagnosis Software Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Brain AI-assisted Diagnosis Software Market Dynamics
- 2.1 Brain AI-assisted Diagnosis Software Industry Trends
- 2.2 Brain AI-assisted Diagnosis Software Industry Drivers
- 2.3 Brain AI-assisted Diagnosis Software Industry Opportunities and Challenges
- 2.4 Brain AI-assisted Diagnosis Software Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Brain AI-assisted Diagnosis Software Revenue by Company (2021-2026)
- 3.2 Global Brain AI-assisted Diagnosis Software Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Brain AI-assisted Diagnosis Software Key Company Head office and Area Served
- 3.4 Global Brain AI-assisted Diagnosis Software Company, Product Type & Application
- 3.5 Global Brain AI-assisted Diagnosis Software Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Brain AI-assisted Diagnosis Software Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Brain AI-assisted Diagnosis Software Players Market Share by Revenue in 2025
- 3.6.3 2025 Brain AI-assisted Diagnosis Software Tier 1, Tier 2, and Tier 3
4 Brain AI-assisted Diagnosis Software Market by Type
- 4.1 Global Brain AI-assisted Diagnosis Software Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Brain AI-assisted Diagnosis Software Market Size by Type (2021-2032)
- 4.3 Global Brain AI-assisted Diagnosis Software Market Size Share by Type (2021-2032)
5 Brain AI-assisted Diagnosis Software Market by Application
- 5.1 Global Brain AI-assisted Diagnosis Software Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Brain AI-assisted Diagnosis Software Market Size by Application (2021-2032)
- 5.3 Global Brain AI-assisted Diagnosis Software Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Deepwise
- 6.1.1 Deepwise Company Information
- 6.1.2 Deepwise Business Overview
- 6.1.3 Deepwise Brain AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Deepwise Brain AI-assisted Diagnosis Software Product Portfolio
- 6.1.5 Deepwise Recent Developments
- 6.2 NeuMiva
- 6.2.1 NeuMiva Company Information
- 6.2.2 NeuMiva Business Overview
- 6.2.3 NeuMiva Brain AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 NeuMiva Brain AI-assisted Diagnosis Software Product Portfolio
- 6.2.5 NeuMiva Recent Developments
- 6.3 G K Healthcare
- 6.3.1 G K Healthcare Company Information
- 6.3.2 G K Healthcare Business Overview
- 6.3.3 G K Healthcare Brain AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 G K Healthcare Brain AI-assisted Diagnosis Software Product Portfolio
- 6.3.5 G K Healthcare Recent Developments
- 6.4 Sense Time
- 6.4.1 Sense Time Company Information
- 6.4.2 Sense Time Business Overview
- 6.4.3 Sense Time Brain AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Sense Time Brain AI-assisted Diagnosis Software Product Portfolio
- 6.4.5 Sense Time Recent Developments
- 6.5 United Imaging
- 6.5.1 United Imaging Company Information
- 6.5.2 United Imaging Business Overview
- 6.5.3 United Imaging Brain AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 United Imaging Brain AI-assisted Diagnosis Software Product Portfolio
- 6.5.5 United Imaging Recent Developments
- 6.6 Infervision
- 6.6.1 Infervision Company Information
- 6.6.2 Infervision Business Overview
- 6.6.3 Infervision Brain AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Infervision Brain AI-assisted Diagnosis Software Product Portfolio
- 6.6.5 Infervision Recent Developments
- 6.7 Shukun
- 6.7.1 Shukun Company Information
- 6.7.2 Shukun Business Overview
- 6.7.3 Shukun Brain AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Shukun Brain AI-assisted Diagnosis Software Product Portfolio
- 6.7.5 Shukun Recent Developments
- 6.8 FOSUN AITROX
- 6.8.1 FOSUN AITROX Company Information
- 6.8.2 FOSUN AITROX Business Overview
- 6.8.3 FOSUN AITROX Brain AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 FOSUN AITROX Brain AI-assisted Diagnosis Software Product Portfolio
- 6.8.5 FOSUN AITROX Recent Developments
- 6.9 BioMind
- 6.9.1 BioMind Company Information
- 6.9.2 BioMind Business Overview
- 6.9.3 BioMind Brain AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 BioMind Brain AI-assisted Diagnosis Software Product Portfolio
- 6.9.5 BioMind Recent Developments
- 6.10 NANO-X
- 6.10.1 NANO-X Company Information
- 6.10.2 NANO-X Business Overview
- 6.10.3 NANO-X Brain AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 NANO-X Brain AI-assisted Diagnosis Software Product Portfolio
- 6.10.5 NANO-X Recent Developments
- 6.11 Aikenist
- 6.11.1 Aikenist Company Information
- 6.11.2 Aikenist Business Overview
- 6.11.3 Aikenist Brain AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Aikenist Brain AI-assisted Diagnosis Software Product Portfolio
- 6.11.5 Aikenist Recent Developments
- 6.12 VUNO
- 6.12.1 VUNO Company Information
- 6.12.2 VUNO Business Overview
- 6.12.3 VUNO Brain AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 VUNO Brain AI-assisted Diagnosis Software Product Portfolio
- 6.12.5 VUNO Recent Developments
7 North America
- 7.1 North America Brain AI-assisted Diagnosis Software Market Size (2021-2032)
- 7.2 North America Brain AI-assisted Diagnosis Software Market Size by Type
- 7.2.1 North America Brain AI-assisted Diagnosis Software Market Size by Type (2021-2026)
- 7.2.2 North America Brain AI-assisted Diagnosis Software Market Size by Type (2027-2032)
- 7.2.3 North America Brain AI-assisted Diagnosis Software Market Share by Type (2021-2032)
- 7.3 North America Brain AI-assisted Diagnosis Software Market Size by Application
- 7.3.1 North America Brain AI-assisted Diagnosis Software Market Size by Application (2021-2026)
- 7.3.2 North America Brain AI-assisted Diagnosis Software Market Size by Application (2027-2032)
- 7.3.3 North America Brain AI-assisted Diagnosis Software Market Share by Application (2021-2032)
- 7.4 North America Brain AI-assisted Diagnosis Software Market Size by Country
- 7.4.1 North America Brain AI-assisted Diagnosis Software Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Brain AI-assisted Diagnosis Software Market Size by Country (2021-2026)
- 7.4.3 North America Brain AI-assisted Diagnosis Software Market Size by Country (2027-2032)
- 7.4.4 North America Brain AI-assisted Diagnosis Software Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Brain AI-assisted Diagnosis Software Market Size (2021-2032)
- 8.2 Europe Brain AI-assisted Diagnosis Software Market Size by Type
- 8.2.1 Europe Brain AI-assisted Diagnosis Software Market Size by Type (2021-2026)
- 8.2.2 Europe Brain AI-assisted Diagnosis Software Market Size by Type (2027-2032)
- 8.2.3 Europe Brain AI-assisted Diagnosis Software Market Share by Type (2021-2032)
- 8.3 Europe Brain AI-assisted Diagnosis Software Market Size by Application
- 8.3.1 Europe Brain AI-assisted Diagnosis Software Market Size by Application (2021-2026)
- 8.3.2 Europe Brain AI-assisted Diagnosis Software Market Size by Application (2027-2032)
- 8.3.3 Europe Brain AI-assisted Diagnosis Software Market Share by Application (2021-2032)
- 8.4 Europe Brain AI-assisted Diagnosis Software Market Size by Country
- 8.4.1 Europe Brain AI-assisted Diagnosis Software Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Brain AI-assisted Diagnosis Software Market Size by Country (2021-2026)
- 8.4.3 Europe Brain AI-assisted Diagnosis Software Market Size by Country (2027-2032)
- 8.4.4 Europe Brain AI-assisted Diagnosis Software Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Brain AI-assisted Diagnosis Software Market Size (2021-2032)
- 9.2 China Brain AI-assisted Diagnosis Software Market Size by Type
- 9.2.1 China Brain AI-assisted Diagnosis Software Market Size by Type (2021-2026)
- 9.2.2 China Brain AI-assisted Diagnosis Software Market Size by Type (2027-2032)
- 9.2.3 China Brain AI-assisted Diagnosis Software Market Share by Type (2021-2032)
- 9.3 China Brain AI-assisted Diagnosis Software Market Size by Application
- 9.3.1 China Brain AI-assisted Diagnosis Software Market Size by Application (2021-2026)
- 9.3.2 China Brain AI-assisted Diagnosis Software Market Size by Application (2027-2032)
- 9.3.3 China Brain AI-assisted Diagnosis Software Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Brain AI-assisted Diagnosis Software Market Size (2021-2032)
- 10.2 Asia Brain AI-assisted Diagnosis Software Market Size by Type
- 10.2.1 Asia Brain AI-assisted Diagnosis Software Market Size by Type (2021-2026)
- 10.2.2 Asia Brain AI-assisted Diagnosis Software Market Size by Type (2027-2032)
- 10.2.3 Asia Brain AI-assisted Diagnosis Software Market Share by Type (2021-2032)
- 10.3 Asia Brain AI-assisted Diagnosis Software Market Size by Application
- 10.3.1 Asia Brain AI-assisted Diagnosis Software Market Size by Application (2021-2026)
- 10.3.2 Asia Brain AI-assisted Diagnosis Software Market Size by Application (2027-2032)
- 10.3.3 Asia Brain AI-assisted Diagnosis Software Market Share by Application (2021-2032)
- 10.4 Asia Brain AI-assisted Diagnosis Software Market Size by Country
- 10.4.1 Asia Brain AI-assisted Diagnosis Software Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Brain AI-assisted Diagnosis Software Market Size by Country (2021-2026)
- 10.4.3 Asia Brain AI-assisted Diagnosis Software Market Size by Country (2027-2032)
- 10.4.4 Asia Brain AI-assisted Diagnosis Software Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Brain AI-assisted Diagnosis Software Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Brain AI-assisted Diagnosis Software Market Size by Type
- 11.2.1 South America, Middle East & Africa Brain AI-assisted Diagnosis Software Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Brain AI-assisted Diagnosis Software Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Brain AI-assisted Diagnosis Software Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Brain AI-assisted Diagnosis Software Market Size by Application
- 11.3.1 South America, Middle East & Africa Brain AI-assisted Diagnosis Software Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Brain AI-assisted Diagnosis Software Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Brain AI-assisted Diagnosis Software Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Brain AI-assisted Diagnosis Software Market Size by Country
- 11.4.1 South America, Middle East & Africa Brain AI-assisted Diagnosis Software Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Brain AI-assisted Diagnosis Software Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Brain AI-assisted Diagnosis Software Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Brain AI-assisted Diagnosis Software Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst